Morningstar Research and Commentary

Novo Nordisk Earnings: Compounders Pressured Q1 Wegovy Sales

We expect disappointing results in the first quarter will be balanced by higher-than-anticipated growth in the second half of the year.

May 8, 2025 - 10:02
 0
Novo Nordisk Earnings: Compounders Pressured Q1 Wegovy Sales
We expect disappointing results in the first quarter will be balanced by higher-than-anticipated growth in the second half of the year.
Read More

Tags:

Previous Article

Trump Tariffs Still Loom Large Over Tech Stocks

Next Article

Alphabet: Apple Search Executive's Testimony Makes Investors Restive About Searc...

Related Posts

Tesla: Search for Elon Musk's Successor Highlights Key Person Risk

Tesla: Search for Elon Musk's Successor Highlights Key ...

May 1, 2025  0

Tesla Stock Sinks Amid Report of Affordable Vehicle Delay

Tesla Stock Sinks Amid Report of Affordable Vehicle Delay

Apr 22, 2025  0

Why Berkshire Hathaway's Stock is Beating the Market in 2025

Why Berkshire Hathaway's Stock is Beating the Market in...

May 1, 2025  0